慢性阻塞性肺疾病患者采用噻托溴胺联合呼吸操训练对肺通气功能生活质量及运动耐力的影响

doi:10.3969/j.issn.1006-6233.2017.10.008

Abstract
Figure/Table
References (13)
Related Citation (6)

Download: PDF (1363 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the effects of tiotropium combined with respiratory exercises on pulmonary ventilation function, quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease (COPD). Methods: 80 patients with COPD enrolled from July 2015 to December 2016 were randomly divided into two groups. The patients in the control group were treated with tiotropiumamine. The patients in the experimental group were treated with respiratory exercises and compared the patients before and after treatment lung function, exercise endurance, dyspnea, quality of life and poor clinical events. Results: Compared with the control group, the levels of FVC, FEV1, FEV1 / FVC, FEV1, MMEF and PEF were significantly higher in the experimental group than those in the control group. Compared with the control group, the 6MWD levels were significantly higher than those in the control group (P <0.05) .Conclusion: Compared with the control group, there was significant difference in the incidence of overall adverse clinical events between the two groups (P> 0.05). The difference between the two groups was statistically significant (P <0.05) P <0.01). Conclusion: The effect of tiotropium combined with respiratory exercises on lung ventilation function, quality of life and exercise tolerance of patients with COPD is significant and safe, which is of great significance.

Key words： COPD Tiotropium Breathing exercises Lung ventilation Exercise endurance

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2017.10.008 OR http://www.hbyxzzs.cn/EN/Y2017/V23/I10/1609

[1]J Steier,T Wessendorf,S Teschler,H Teschler. Cardiorespiratory effects of pursed-Lips-breathing during 6-minute-walk-test in patients with severe COPD[J].Physioscience,2008,4(3): 2609~2614
[2] 葛均波,徐永健,主编.内科学[J].第8版.北京.人民卫生出版社,2013.297~368.
[3] 姚婉贞.慢性阻塞性肺疾病病情和预后评估指标新认识[J].中华医学杂志,2015,101(8):561~563.
[4] 李岩.健康教育路径应用于慢性阻塞性肺疾病住院患者的效果[J].中国健康教育,2016,32(7):652~654.
[5] 谭芳,刘凌,王成.康复训练联合吸入噻托溴胺和沙美特罗/氟替卡松对稳定期慢性阻塞性肺疾病患者运动耐力的影响[J].中国老年保健医学,2012,10(2):18~19.
[6] 谭芳,刘凌.康复训练联合吸入噻托溴胺和沙美特罗/氟替卡松对稳定期慢性阻塞性肺疾病患者的康复疗效[J].云南医药,2013,56(1):4~8.
[7] 余佳.噻托溴胺与克拉霉素联合治疗慢性阻塞性肺疾病的临床观察[J].北方药学,2016,13(3):86~87.
[8] 陈钢,朱凡特.吸入噻托溴胺联合沙美特罗替卡松对稳定期慢性阻塞性肺疾病患者肺功能及生活质量的影响[J].实用心脑肺血管病杂志,2013,21(8):16~17.
[9] H Geldmacher,H Biller,A Herbst,et al.The prevalence of chronic obstructive pulmonarydisease (COPD) in Germany[J].Dtsch med Wochenschr,2008,133(50): 120~124
[10] 卓致远,武焱旻.噻托溴胺联合呼吸操训练治疗稳定期慢性阻塞性肺病患者的临床研究[J].临床肺科杂志,2016,21(12):2287~2290.
[11] 李娥.慢性阻塞性肺疾病合并慢性呼吸衰竭患者应用家庭无创通气的护理干预[J].护士进修杂志,2011,26(10):949~950.
[12] 苏金明.噻托溴胺治疗稳定期慢性阻塞性肺疾病的临床观察[J].河北医药,2013,35(6):850~851.
[13] 郑世良.噻托溴胺对老年人慢性阻塞性肺疾病稳定期运动能力和肺功能的影响[J].临床荟萃,2011,26(19):1722~1724.